Clarient Inc

1 known investors

NeoGenomics provides precision oncology testing and genomic profiling services to support personalized cancer care for oncologists, biopharma partners, and patients. The company offers over 500 diagnostic tests across multiple modalities including NGS, immunohistochemistry, and liquid biopsies, leveraging a dataset of 2+ million patient profiles.